Mono Pharmacare Ltd (MONOPHARMA) share fundamentals
Mono Pharmacare Ltd is a micro-cap company in Consumer Discretionary (Retail - Speciality) with a market capitalisation of ₹17 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Consumer Discretionary company.
Financial health score
Out of 100, across five pillars of reported fundamentals.
What stands out
- Debt/equity 1.79x — heavily leveraged
- Interest cover 1.3x — earnings barely cover interest
- Positive free cash flow and profitable
Mono Pharmacare Ltd vs the Consumer Discretionary median
| Metric | MONOPHARMA | Sector median | |
|---|---|---|---|
| PE ratioprice paid for each rupee of yearly profit | 48.72x | 17.44x | Weaker |
| Price to bookprice against the book value of assets | 0.54x | 1.75x | Better |
| EV / EBITDAbusiness value against operating profit | 16.1x | 11.94x | Weaker |
| Dividend yieldyearly dividend as a share of price | — | 0.6% | |
| Return on equityprofit on shareholders’ money | 2.3% | 8% | Weaker |
| ROCEprofit on all capital employed | 7.5% | 11.1% | Weaker |
| Net profit marginprofit kept from each rupee of sales | 0.4% | 3.8% | Weaker |
| Debt to equityborrowing against shareholders’ money | 1.79x | 0.31x | Weaker |
| Interest coveragehow many times profit covers interest | 1.33x | 3.69x | Weaker |
| Current ratioshort-term assets against short-term dues | 1.92x | 1.82x | In line |
| Revenue growth (1Y)change in sales over a year | -2.1% | 10.6% | Weaker |
| EPS growth (1Y)change in earnings per share over a year | -76.2% | 8.9% | Weaker |
| Promoter holdingshare owned by the founders or parent | 56.8% | 61.2% | In line |
| Promoter pledgepromoter shares pledged as loan security | 0% | 0% | In line |
| Betahow much it moves with the market | — | 1 | |
| 1-year returnshare price change over 52 weeks | -52.4% | -15.4% |
Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.
Other Consumer Discretionary companies
Titan Company LtdTITAN · score 61.6
Maruti Suzuki India LtdMARUTI · score 75.3
Mahindra and Mahindra LtdM&M · score 70
Bajaj Auto Ltd.BAJAJ-AUTO · score 83.2
Avenue Supermarts LtdDMART · score 67.6
TVS Motor Company LimitedTVSMOTOR · score 53.6
Samvardhana Motherson International LimitedMOTHERSON · score 55
Hyundai Motor India LtdHYUNDAI · score 67.6
Trent LtdTRENT · score 63.9
Bosch LtdBOSCHLTD · score 77.7
Indian Hotels Company LtdINDHOTEL · score 71.3
Lenskart Solutions LtdLENSKART · score 50.7Frequently asked questions
What is the PE ratio of Mono Pharmacare Ltd?
Mono Pharmacare Ltd trades at a PE of 48.72x as of 5 November 2026, against a Consumer Discretionary median of 17.44x. PE is the price paid for each rupee of yearly profit.
Is Mono Pharmacare Ltd debt free?
No. Mono Pharmacare Ltd has a debt-to-equity ratio of 1.79x, against a Consumer Discretionary median of 0.31x.
What is the ROCE and ROE of Mono Pharmacare Ltd?
Mono Pharmacare Ltd has a return on capital employed of 7.5% and a return on equity of 2.3%. The Consumer Discretionary medians are 11.1% and 8%.
What is the DecideChart health score of Mono Pharmacare Ltd?
Mono Pharmacare Ltd scores 40.5 out of 100, graded Caution. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.
Should I buy Mono Pharmacare Ltd shares?
DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Mono Pharmacare Ltd with its Consumer Discretionary peers, and consult a SEBI-registered adviser before investing.
Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.